Literature DB >> 12869305

Malignancy-associated regions of transcriptional activation: gene expression profiling identifies common chromosomal regions of a recurrent transcriptional activation in human prostate, breast, ovarian, and colon cancers.

Gennadi V Glinsky1, Anja Krones-Herzig, Anna B Glinskii.   

Abstract

Despite remarkable advances in our understanding of a genetic basis of cancer, the precise molecular definition of the phenotypically relevant genetic features associated with human epithelial malignancies remains a significant and highly relevant challenge. Here we performed a systematic analysis of the chromosomal positions of cancer-associated transcripts for prostate, breast, ovarian, and colon tumors, and identified short segments of human chromosomes that appear to represent a common target for transcriptional activation in major epithelial malignancies in human. These cancer-associated transcriptomeres correspond well to the regions of transient transcriptional activity on chromosomes 1q21-q23 (144-160 Mbp), 12q13 (52-63 Mbp), 17q21 (38-50 Mbp), 17q23-q25 (72-82 Mbp), 19p13 (1-16 Mbp), and Xq28 (132-142 Mbp) during human cell cycle, suggesting a common epigenetic mechanism of transcriptional activation. Consistent with this idea, two of these transcriptomeres (12q13 and 17q21) seemed to be related to the p53-regulated transcriptional clusters, and some of the cancer-associated transcriptomeres appeared to correspond well to the recently identified regions of increased gene expression on human chromosomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869305      PMCID: PMC1502409          DOI: 10.1016/S1476-5586(03)80054-4

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  21 in total

1.  Transcriptional regulation and function during the human cell cycle.

Authors:  R J Cho; M Huang; M J Campbell; H Dong; L Steinmetz; L Sapinoso; G Hampton; S J Elledge; R W Davis; D J Lockhart
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

2.  Genome-wide analysis of DNA copy-number changes using cDNA microarrays.

Authors:  J R Pollack; C M Perou; A A Alizadeh; M B Eisen; A Pergamenschikov; C F Williams; S S Jeffrey; D Botstein; P O Brown
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

Review 3.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

4.  Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis.

Authors:  S Ishida; E Huang; H Zuzan; R Spang; G Leone; M West; J R Nevins
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling.

Authors:  G Geiss; G Jin; J Guo; R Bumgarner; M G Katze; G C Sen
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

6.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

Authors:  J B Welsh; P P Zarrinkar; L M Sapinoso; S G Kern; C A Behling; B J Monk; D J Lockhart; R A Burger; G M Hampton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

7.  Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays.

Authors:  D A Notterman; U Alon; A J Sierk; A J Levine
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

8.  The human transcriptome map: clustering of highly expressed genes in chromosomal domains.

Authors:  H Caron; B van Schaik ; M van der Mee ; F Baas; G Riggins; P van Sluis ; M C Hermus; R van Asperen ; K Boon; P A Voûte; S Heisterkamp; A van Kampen ; R Versteeg
Journal:  Science       Date:  2001-02-16       Impact factor: 47.728

9.  Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.

Authors:  F Forozan; E H Mahlamäki; O Monni; Y Chen; R Veldman; Y Jiang; G C Gooden; S P Ethier; A Kallioniemi; O P Kallioniemi
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

10.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

View more
  11 in total

1.  Predicting the clinical course of prostate cancer.

Authors:  James McKiernan; Mitchell C Benson
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

2.  ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.

Authors:  Rainer Kuefer; Kathleen C Day; Celina G Kleer; Michael S Sabel; Matthias D Hofer; Sooryanarayana Varambally; Christoph S Zorn; Arul M Chinnaiyan; Mark A Rubin; Mark L Day
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

Review 3.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

4.  Paxillin regulated genomic networks in prostate cancer.

Authors:  Xiaoting Ma; Anindita Biswas; Stephen R Hammes
Journal:  Steroids       Date:  2019-07-22       Impact factor: 2.668

Review 5.  A review on research progress of transketolase.

Authors:  Jing Zhao; Chun-Jiu Zhong
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203

6.  Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer.

Authors:  Robyn L Prueitt; Ming Yi; Robert S Hudson; Tiffany A Wallace; Tiffany M Howe; Harris G Yfantis; Dong H Lee; Robert M Stephens; Chang-Gong Liu; George A Calin; Carlo M Croce; Stefan Ambs
Journal:  Prostate       Date:  2008-08-01       Impact factor: 4.104

7.  Gene expression profiling predicts clinical outcome of prostate cancer.

Authors:  Gennadi V Glinsky; Anna B Glinskii; Andrew J Stephenson; Robert M Hoffman; William L Gerald
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

8.  mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.

Authors:  J P Baren; G D Stewart; A Stokes; K Gray; C J Pennington; R O'Neill; D A C Deans; S Paterson-Brown; A C P Riddick; D R Edwards; K C H Fearon; J A Ross; R J E Skipworth
Journal:  Br J Cancer       Date:  2012-06-07       Impact factor: 7.640

9.  In-silico identification and functional validation of allele-dependent AR enhancers.

Authors:  Sonia Garritano; Alessandro Romanel; Yari Ciribilli; Alessandra Bisio; Antoneta Gavoci; Alberto Inga; Francesca Demichelis
Journal:  Oncotarget       Date:  2015-03-10

10.  Topoisomerase II inhibition involves characteristic chromosomal expression patterns.

Authors:  Susanne Reymann; Jürgen Borlak
Journal:  BMC Genomics       Date:  2008-07-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.